MRNA Announcements Filter Options Archive DateYear20262025202420232022202120202019201820172016201520142013201220112010200920082007MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Type UpdatesPerspectives View 12 View 12View 24View 48 Categories Breaking NewsEmployeesEventsGuidanceHiring & RecruitmentPerspectivesUpdates & Statements• • • Keywords All Keywords AccordAlbert BourlaAlopeciaAnnual ReportAntibioticsAntimicrobial ResistanceArtificial IntelligenceAtrial FibrillationAutoimmune DiseasesBiologics & BiosimilarsBlood CancerBreast CancerBusinessC DifficileCOVID-19 Vaccine EffortsCancerCardiovascular DiseaseCareersClinical TrialsColon CancerColorectal CancerCounterfeit MedicinesCovid-19DiabetesDiseases & ConditionsDiversity & InclusionDuchenne Muscular DystrophyEczemaEmerging MedicineEmployeesEnvironmentFinanceFungal InfectionsGaucher Hormone DeficiencyGene TherapyGovernmentGrowth Hormone DeficiencyHealth EquityHealth LiteracyHemophiliaHistoryHypertensionImmune SystemInfectious diseasesInfluenzaInvestmentsKidney CancerLeadershipLeukemiaLung CancerLupusLyme DiseaseManufacturingMaternal ImmunizationMedicinal ScienceMedicinesMeningococcal DiseaseMigrainesNASHOncologyOpioidPartnershipsPatient CentricityPatient StoriesPediatricsPfizer CulturePneumoccocal DiseasePneumococcal DiseasePneumoniaPrecision MedicineProstate CancerPsoriasisPulmonary HypertensionRare DiseasesResearchRespiratory Syncytial VirusResponsibilityRheumatoid ArthritisScience Will WinScience in the EverydaySickle Cell DiseaseSkin ConditionsTechnologyTransthyretin Amyloidosis (ATTR)Ulcerative ColitisUnderstanding ConditionsVaccinesVitiligoWellnessWomen's HealthmRNAmigraine October 2023 10.16.2023 Easing the Healthcare Burden of the Seasonal Triple-demic and Pfizer’s Unwavering Commitment to Public HealthCovid-19Diseases & ConditionsInfluenzamRNAResearchRespiratory Syncytial VirusVaccines • • • March 2021 03.09.2021 Albert Bourla Reflects on the One Year Anniversary of the COVID-19 PandemicPerspectivesAlbert BourlaBusinessClinical TrialsCovid-19Diseases & ConditionsLeadershipmRNAPartnershipsPatient CentricityTechnologyVaccinesWellness • • • January 2021 01.22.2021 Albert Bourla On Ensuring Equitable Access to COVID-19 VaccinesPerspectivesAlbert BourlaBusinessCovid-19Diseases & ConditionsmRNAPartnershipsPatient CentricityResponsibilityVaccines • • •
